Evotec SE Statistics
Total Valuation
Evotec SE has a market cap or net worth of $690.62 million. The enterprise value is $702.55 million.
| Market Cap | 690.62M |
| Enterprise Value | 702.55M |
Important Dates
The last earnings date was Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Evotec SE has 177.67 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 177.67M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.23% |
| Owned by Institutions (%) | 31.50% |
| Float | 135.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.84 |
| Forward PS | 1.07 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 1.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.71.
| Current Ratio | 2.33 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.08% and return on invested capital (ROIC) is -22.13%.
| Return on Equity (ROE) | -26.08% |
| Return on Assets (ROA) | -5.39% |
| Return on Invested Capital (ROIC) | -22.13% |
| Return on Capital Employed (ROCE) | -11.56% |
| Weighted Average Cost of Capital (WACC) | 6.27% |
| Revenue Per Employee | $183,697 |
| Profits Per Employee | -$50,464 |
| Employee Count | 4,461 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 17.96 |
Taxes
In the past 12 months, Evotec SE has paid $15.14 million in taxes.
| Income Tax | 15.14M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.27% in the last 52 weeks. The beta is 1.26, so Evotec SE's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | -45.27% |
| 50-Day Moving Average | 2.22 |
| 200-Day Moving Average | 2.86 |
| Relative Strength Index (RSI) | 40.37 |
| Average Volume (20 Days) | 61,593 |
Short Selling Information
The latest short interest is 50,740, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 50,740 |
| Short Previous Month | 47,630 |
| Short % of Shares Out | 0.01% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.64 |
Income Statement
In the last 12 months, Evotec SE had revenue of $819.47 million and -$225.12 million in losses. Loss per share was -$1.27.
| Revenue | 819.47M |
| Gross Profit | 69.36M |
| Operating Income | -166.64M |
| Pretax Income | -209.98M |
| Net Income | -225.12M |
| EBITDA | -83.61M |
| EBIT | -166.64M |
| Loss Per Share | -$1.27 |
Balance Sheet
The company has $531.92 million in cash and $543.66 million in debt, with a net cash position of -$11.74 million or -$0.07 per share.
| Cash & Cash Equivalents | 531.92M |
| Total Debt | 543.66M |
| Net Cash | -11.74M |
| Net Cash Per Share | -$0.07 |
| Equity (Book Value) | 760.40M |
| Book Value Per Share | 4.28 |
| Working Capital | 475.75M |
Cash Flow
In the last 12 months, operating cash flow was -$133.26 million and capital expenditures -$55.82 million, giving a free cash flow of -$189.08 million.
| Operating Cash Flow | -133.26M |
| Capital Expenditures | -55.82M |
| Depreciation & Amortization | 84.19M |
| Net Borrowing | -19.66M |
| Free Cash Flow | -189.08M |
| FCF Per Share | -$1.06 |
Margins
Gross margin is 8.46%, with operating and profit margins of -20.33% and -27.47%.
| Gross Margin | 8.46% |
| Operating Margin | -20.33% |
| Pretax Margin | -25.62% |
| Profit Margin | -27.47% |
| EBITDA Margin | -10.20% |
| EBIT Margin | -20.33% |
| FCF Margin | n/a |
Dividends & Yields
Evotec SE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.08% |
| Shareholder Yield | -0.08% |
| Earnings Yield | -32.60% |
| FCF Yield | -27.38% |
Analyst Forecast
The average price target for Evotec SE is $3.85, which is 101.57% higher than the current price. The consensus rating is "Hold".
| Price Target | $3.85 |
| Price Target Difference | 101.57% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -0.15% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 20, 2021. It was a forward split with a ratio of 4:1.
| Last Split Date | Oct 20, 2021 |
| Split Type | Forward |
| Split Ratio | 4:1 |
Scores
Evotec SE has an Altman Z-Score of 0.3 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.3 |
| Piotroski F-Score | 4 |